(Total Views: 647)
Posted On: 05/15/2020 7:57:04 PM
Post# of 154062
All true and sorry for omitting...
but that's actually TWO important factors
We have no idea about the safety profile of these other antibodies... they may be as innocuous as Leronlimab, they might cause severe issues like Sarilumab and Tocilizumab... we'll have to see. Speed of recovery is also an unknown for any other potential treatments. Leronlimab is phenomenal in both categories, from what I've seen so far... won't be easy to beat.
but that's actually TWO important factors
Quote:
I'll only add one more important factor... Leronlimab has very little, if any, negative side effects and seemingly a quicker positive reaction... remember what Dr. Lalezari said a couple of days ago:
Quote:
Most patients are showing great improvement by day three... surprising how quickly getting much better
Read More: https://investorshangout.com/post/newpost/605...z6MYecMwU8
We have no idea about the safety profile of these other antibodies... they may be as innocuous as Leronlimab, they might cause severe issues like Sarilumab and Tocilizumab... we'll have to see. Speed of recovery is also an unknown for any other potential treatments. Leronlimab is phenomenal in both categories, from what I've seen so far... won't be easy to beat.
(1)
(0)
